UBE2N as a novel prognostic and therapeutic biomarker of lung adenocarcinoma.

Front Immunol · 2025 · PMC12375651 · PMID 40861472

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significanceP = 0.06so close (0.05 < p ≤ 0.1)

Conversely, LUAD patients with high USP44 expression exhibited prolonged overall survival, although this association did not reach statistical significance in the GSE19188 dataset ( P = 0.06 and P < 0.05; Figures 2C, D ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.